Skip to main content
AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
8,505.50
+40.00 (0.47%)
Apr 29, 2026, 9:57 AM IST

AstraZeneca Pharma India Revenue

AstraZeneca Pharma India had revenue of 6.12B INR in the quarter ending December 31, 2025, with 38.90% growth. This brings the company's revenue in the last twelve months to 21.77B, up 34.49% year-over-year. In the fiscal year ending March 31, 2025, AstraZeneca Pharma India had annual revenue of 17.16B with 32.48% growth.

Revenue (ttm)
21.77B
Revenue Growth
+34.49%
P/S Ratio
9.71
Revenue / Employee
36.29M
Employees
600
Market Cap
211.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202517.16B4.21B32.48%
Mar 31, 202412.96B2.93B29.17%
Mar 31, 202310.03B1.97B24.50%
Mar 31, 20228.06B-79.60M-0.98%
Mar 31, 20218.14B-182.50M-2.19%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Piramal Pharma 88.71B
Wockhardt 31.74B
NATCO Pharma 45.63B
Eris Lifesciences 30.65B
Cohance Lifesciences 10.79B
Gland Pharma 61.13B
Emcure Pharmaceuticals 88.50B
Alembic Pharmaceuticals 72.67B
Revenue Rankings

AstraZeneca Pharma India News

More News